Soligenix Lights the Way with Positive T-Cell Lymphoma Data BioWorld

Soligenix Lights the Way with Positive T-Cell Lymphoma Data BioWorld

Soligenix Inc. Reports Positive Interim Update for Cancer Therapy and Light Device

Soligenix Inc., a Princeton-based pharmaceutical company, reported a positive interim update on Hybryte, its cancer therapy and light device for treating early stage cutaneous T-cell lymphoma. Investors responded with great enthusiasm, catapulting Soligenix’s stock (NASDAQ:SNGX) upwards by a whopping 464% before closing at a still impressive 271% increase to $7.42 per share on July 9.

Alzheon Inc. Raises $100 Million in Financing Round for Alzheimer’s Drug

Alzheon Inc. recently raised $100 million in a series E financing round to accelerate the development of its oral candidate drug, ALZ-801, for early Alzheimer’s disease (AD). The drug has a targeted mechanism that could help prevent the formation of toxic amyloid oligomers, which is a hallmark of AD.

Annovis Bio Inc. Reports Promising Phase III Parkinson’s Disease Data

Following a data-cleaning delay and mixed results in Alzheimer’s disease, Annovis Bio Inc. reported promising phase III data in treating Parkinson’s disease. The drug, which targeted cognitive and motor function, showed improvement in both areas, and the lessening of disease progression and severity. Further development of the drug will be based on these positive results.

Politan Capital Management LP’s Efforts to Control Masimo Corp. Board Fails

Politan Capital Management LP, an activist investor, lost a years-long effort to control the board of directors for Masimo Corp. and to oust the company’s CEO and founder. Masimo Corp. has been successful in fending off this attempt and plans to continue developing its noninvasive monitoring technologies for patient care.

BioWorld Offers Extended Coverage for a Comprehensive Market View

If you’re interested in staying up-to-date on the latest developments in healthcare, treatments, research, and alternative medicines, BioWorld offers an online healthcare magazine that provides comprehensive coverage from around the world. Subscribe to BioWorld, BioWorld MedTech, and BioWorld Asia for easier and more convenient access to the most vital news and information.

Originally Post From

Read more about this topic at
Railway Stocks Soar High Amid Block-Deal Rumours
Railway Stocks Soar High Amid Block-Deal Rumours

Advancing Treatment for EGFR-Mutant Advanced NSCLC Lessons from FLAURA2

Sunvozertinib Shows Promise in Treating Pretreated EGFR+ Lung Cancer